Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Contact us
^
Login
BIOMARKER:
FGFR3 S249C
i
Other names:
FGFR3, ACH, CD333, CEK2, JTK4, Fibroblast growth factor receptor 3
Entrez ID:
2261
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(10)
Heatmap
News
Twitter
Trials
Reset Filters
Veri cancer hierarchy
x
x
x
x
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
BGJ398
Sensitive: C3 – Early Trials
BGJ398
Sensitive
:
C3
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
erdafitinib
Sensitive: C3 – Early Trials
erdafitinib
Sensitive
:
C3
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
FGFR2 inhibitor
Resistant: C3 – Early Trials
FGFR2 inhibitor
Resistant
:
C3
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
FGFR3 inhibitor
Resistant: C3 – Early Trials
FGFR3 inhibitor
Resistant
:
C3
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
pazopanib
Sensitive: C4 – Case Studies
pazopanib
Sensitive
:
C4
FGFR3 S249C
FGFR3 S249C
Lung Adenocarcinoma
LUAD
BGJ398
Sensitive: D – Preclinical
BGJ398
Sensitive
:
D
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
AZ8010
Sensitive: D – Preclinical
AZ8010
Sensitive
:
D
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
PD 0173074
Sensitive: D – Preclinical
PD 0173074
Sensitive
:
D
FGFR3 S249C
FGFR3 S249C
Urothelial Cancer
Urothelial Cancer
ABSK-091
Sensitive: D – Preclinical
ABSK-091
Sensitive
:
D
FGFR3 S249C
FGFR3 S249C
Bladder Cancer
Bladder Cancer
ponatinib
Sensitive: D – Preclinical
ponatinib
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended to be a substitute for medical advice.
For commercial access, including additional premium features, please
contact us.
By using VERI, you are agreeing to our
Terms of Use
and
Privacy Policy
ACCEPT COOKIES
^
^
